 |
Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines: Results From a High-Prevalence Area CME DisclosuresRelease Date: January 25, 2008; Valid for credit through January 25, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| The content of this CME activity, "Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines: Results From a High-Prevalence Area," was developed by the faculty.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
The US Centers for Disease Control and Prevention recommends more aggressive strategies for screening for HIV infection, and the current study describes efforts at one major metropolitan emergency department to implement such a policy. Routine HIV Screening in the Emergency Department Using the New US Centers for Disease Control and Prevention Guidelines: Results From a High-Prevalence Area
Jeremy Brown, MD
Robert Shesser
Gary Simon, MD
Maria Bahn
Maggie Czarnogorski, MD
Irene Kuo, PhD
Manya Magnus, PhD
Neal Sikka, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe HIV screening guidelines from the US Centers for Disease Control and Prevention
- Identify demographic information in the current study
- Specify the results and follow-up of HIV screening in the current
study
Authors and Disclosures Jeremy Brown, MD
Disclosure: Jeremy Brown, MD, has disclosed no relevant financial relationships. Robert Shesser
Disclosure: Robert Shesser has disclosed no relevant financial relationships. Gary Simon,
MD
Disclosure: Gary Simon, MD, has disclosed no relevant financial relationships. Maria Bahn
Disclosure: Maria Bahn has disclosed no relevant financial relationships. Maggie Czarnogorski, MD
Disclosure: Maggie Czarnogorski, MD, has disclosed no relevant financial relationships. Irene Kuo,
PhD
Disclosure: Irene Kuo, PhD, has disclosed no relevant financial relationships. Manya Magnus, PhD
Disclosure: Manya Magnus, PhD, has disclosed no relevant financial relationships. Neal Sikka, MD
Disclosure: Neal Sikka, MD, has disclosed no relevant financial relationships. Charles P. Vega,
MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
